ORSUCCI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 6.493
AS - Asia 2.195
EU - Europa 2.021
SA - Sud America 413
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 89
OC - Oceania 6
Totale 11.347
Nazione #
US - Stati Uniti d'America 6.315
SG - Singapore 651
CN - Cina 611
IT - Italia 553
DE - Germania 417
HK - Hong Kong 361
BR - Brasile 346
SE - Svezia 289
VN - Vietnam 167
BG - Bulgaria 161
GB - Regno Unito 143
CA - Canada 126
TR - Turchia 116
RU - Federazione Russa 87
FR - Francia 83
IN - India 81
FI - Finlandia 74
UA - Ucraina 69
AT - Austria 47
JP - Giappone 44
CI - Costa d'Avorio 41
BD - Bangladesh 33
CH - Svizzera 26
IQ - Iraq 26
NG - Nigeria 22
AR - Argentina 17
MX - Messico 15
PK - Pakistan 15
SN - Senegal 15
ES - Italia 14
ZA - Sudafrica 14
BE - Belgio 13
NL - Olanda 12
VE - Venezuela 12
PL - Polonia 11
SA - Arabia Saudita 10
CO - Colombia 9
UZ - Uzbekistan 9
MA - Marocco 8
CL - Cile 7
EG - Egitto 7
ID - Indonesia 7
PH - Filippine 7
EC - Ecuador 6
HN - Honduras 6
JO - Giordania 6
KE - Kenya 6
KR - Corea 6
MY - Malesia 6
PE - Perù 6
UY - Uruguay 6
AU - Australia 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
BJ - Benin 4
CR - Costa Rica 4
IL - Israele 4
NI - Nicaragua 4
NP - Nepal 4
OM - Oman 4
PA - Panama 4
PY - Paraguay 4
BB - Barbados 3
DZ - Algeria 3
IE - Irlanda 3
LB - Libano 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GQ - Guinea Equatoriale 1
GT - Guatemala 1
HU - Ungheria 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 11.247
Città #
Woodbridge 770
Houston 620
Ashburn 592
Fairfield 539
Ann Arbor 432
Singapore 379
Hong Kong 351
Santa Clara 334
Chandler 287
Dallas 249
Seattle 246
San Jose 244
Wilmington 188
Cambridge 164
Milan 163
Serra 163
Sofia 161
Shanghai 146
Beijing 122
New York 108
Jacksonville 104
Ottawa 103
Los Angeles 95
Council Bluffs 86
Frankfurt am Main 79
Izmir 79
Princeton 69
Boardman 68
Lawrence 63
Medford 62
Lauterbourg 55
Florence 53
Nanjing 47
Abidjan 41
Vienna 41
Ho Chi Minh City 40
Tokyo 39
São Paulo 35
Des Moines 34
San Diego 32
Lancaster 29
Munich 28
Columbus 27
Dong Ket 26
London 26
Bern 25
Istanbul 25
Nanchang 25
Buffalo 24
Dearborn 24
Ogden 24
Lagos 22
The Dalles 22
Redondo Beach 21
Rome 21
Hanoi 20
Bremen 19
Pune 18
Changsha 17
Jüchen 17
Fuzhou 16
Dakar 15
Hefei 14
Rio de Janeiro 14
Norwalk 13
Baghdad 12
Belo Horizonte 12
Chennai 12
Düsseldorf 12
Hebei 12
Orem 11
Shenyang 11
Brussels 10
Jiaxing 10
Redwood City 10
Turku 10
Warsaw 10
Curitiba 9
San Francisco 9
Tashkent 9
Brasília 8
Dhaka 8
Toronto 8
Atlanta 7
Brooklyn 7
Denver 7
Helsinki 7
Kent 7
Kunming 7
Manchester 7
Quanzhou 7
Amman 6
Caxias do Sul 6
Detroit 6
Montreal 6
Seoul 6
Chicago 5
Erbil 5
Johannesburg 5
Kuala Lumpur 5
Totale 8.304
Nome #
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 270
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 247
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 241
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 234
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects 233
Tetracycline treatment in patients with progressive external ophthalmoplegia. 233
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 229
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 223
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 221
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 218
Mitochondria, cognitive impairment, and Alzheimer's disease. 217
Psychiatric involvement in adult patients with mitochondrial disease. 212
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 210
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 209
Inflammatory myopathy in a patient with postural and kinetik tremor. 206
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 204
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 199
Mitochondrial DNA single deletion in a patient with postural tremor. 198
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 197
Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. 197
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 197
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 195
Mitochondrial DNA sequence variation and neurodegeneration. 194
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 194
Cardiac involvement in chronic progressive external ophthalmoplegia 193
Subacute Alzheimer’s disease with prominent white matter involvement. Report of a pathologically-confirmed case 189
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 188
Drugs and mitochondrial diseases: 40 queries and answers. 183
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 181
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. 180
Common Genetic Conditions of Ischemic Stroke to Keep in Mind 180
POLG1-related and other "mitochondrial Parkinsonisms": an overview. 177
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 172
Redefining phenotypes associated with mitochondrial DNA single deletion 172
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15. 171
Myoclonus in mitochondrial disorders 169
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 169
.Is there a primary role of the mitochondrial genome in Alzheimer's disease? 163
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15. 162
Psychiatric involvement in adult patients with mitochondrial disease. 160
Robotic gait training improves motor skills and quality of life in hereditary spastic paraplegia 158
NEWS and VIEWS: mitochondrial encephalomyopathies 156
Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines? 155
Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: a case report and an update on the state of art. 154
Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. 153
Revisiting mitochondrial ocular myopathies: a study from the Italian Network 152
Anti-Ri-associated paraneoplastic cerebellar degeneration. Report of a case and revision of the literature. 151
Creutzfeldt-Jakob disease with E200K PRNP mutation: a case report and revision of the literature 151
The m.3243A>G mitochondrial DNA mutation and related phenotypes. A matter of gender? 151
Current and emerging treatment options in the management of Friedreich ataxia. 144
Revealing the Complexity of Mitochondrial DNA-Related Disorders 140
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 140
Psychiatric involvement in adult patients with mitochondrial disease. 139
Erratum: Redefining phenotypes associated with mitochondrial DNA single deletion (J Neurol, (2015) 262, (1301-1309), DOI 10.1007/s00415-015-7710-y) 138
Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease 137
Oxidative stress biomarkers are related to disease severity in mitochondrial myopathies, and may be modified by a cysteine donor 135
Reply to: Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment. 135
Tetracyclines and neuromuscular disorders 134
The genetics of ataxia: Through the labyrinth of the Minotaur, looking for Ariadne's thread 131
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation 128
Oxidative stress biomarkers are related to disease severity in mitochondrial myopathies, and may be modified by a cysteine donor 128
Quality of life in adult patients with mitochondrial myopathy. 125
Corrigendum to “Response to: Mitochondrial neuropathy affects peripheral and cranial nerves and is primary or secondary or both” [Neuromuscular Disorders 26/8 (2016) 549](S0960896616302899)(10.1016/j.nmd.2016.06.007) 110
null 89
Advances in molecular diagnostics for mitochondrial diseases 26
Totale 11.347
Categoria #
all - tutte 32.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 0 21 41 129 87 14 47 22 15 59 179
2022/2023971 83 133 74 73 96 123 6 82 207 6 81 7
2023/2024652 86 77 77 37 91 128 17 13 9 17 48 52
2024/20252.271 4 69 8 128 261 213 258 109 179 250 202 590
2025/20261.833 148 219 230 132 226 175 291 117 61 134 66 34
2026/2027388 25 183 180 0 0 0 0 0 0 0 0 0
Totale 11.347